3/17
04:43 pm
rprx
Royalty Pharma Announces Expansion of Leadership Team [Yahoo! Finance]
Low
Report
Royalty Pharma Announces Expansion of Leadership Team [Yahoo! Finance]
3/17
04:01 pm
rprx
Royalty Pharma Announces Expansion of Leadership Team
Low
Report
Royalty Pharma Announces Expansion of Leadership Team
3/3
07:33 pm
rprx
Royalty Pharma plc (RPRX) Earns $51 Target as 2026 Growth Outlook Exceeds Expectations [Yahoo! Finance]
Low
Report
Royalty Pharma plc (RPRX) Earns $51 Target as 2026 Growth Outlook Exceeds Expectations [Yahoo! Finance]
3/3
03:57 pm
rprx
Royalty Pharma plc (RPRX) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Neutral
Report
Royalty Pharma plc (RPRX) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
3/3
05:32 am
rprx
Royalty Pharma (RPRX) Achieves Record Growth and Hits Investment Targets Ahead of Schedule [Yahoo! Finance]
Low
Report
Royalty Pharma (RPRX) Achieves Record Growth and Hits Investment Targets Ahead of Schedule [Yahoo! Finance]
3/2
09:15 pm
rprx
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
Low
Report
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
3/2
07:35 am
rprx
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform [Yahoo! Finance]
Medium
Report
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform [Yahoo! Finance]
3/2
07:00 am
rprx
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
Medium
Report
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
3/2
06:43 am
rprx
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing [Yahoo! Finance]
Medium
Report
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing [Yahoo! Finance]
3/2
06:13 am
rprx
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/2
06:10 am
rprx
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
Medium
Report
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
3/1
04:34 am
rprx
TD Cowen Lifts PT on Royalty Pharma Plc (RPRX) to $50 from $45, Here's Why [Yahoo! Finance]
Medium
Report
TD Cowen Lifts PT on Royalty Pharma Plc (RPRX) to $50 from $45, Here's Why [Yahoo! Finance]
2/27
04:14 pm
rprx
Royalty Pharma (RPRX) had its "buy" rating reaffirmed by TD Cowen.
Low
Report
Royalty Pharma (RPRX) had its "buy" rating reaffirmed by TD Cowen.
2/26
04:43 pm
rprx
Royalty Pharma to Present at TD Cowen's 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
Royalty Pharma to Present at TD Cowen's 46th Annual Health Care Conference [Yahoo! Finance]
2/26
04:15 pm
rprx
Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference
Low
Report
Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference
2/21
09:12 am
rprx
Teva, Medincell granted FDA review for long-acting antipsychotic [Seeking Alpha]
Low
Report
Teva, Medincell granted FDA review for long-acting antipsychotic [Seeking Alpha]
2/16
03:43 am
rprx
Royalty Pharma: 2025 Financial Performance And Strategic Outlook [Seeking Alpha]
Low
Report
Royalty Pharma: 2025 Financial Performance And Strategic Outlook [Seeking Alpha]
2/15
08:02 am
rprx
Royalty Pharma plc (NASDAQ:RPRX) Passed Our Checks, And It's About To Pay A US$0.235 Dividend [Yahoo! Finance]
Low
Report
Royalty Pharma plc (NASDAQ:RPRX) Passed Our Checks, And It's About To Pay A US$0.235 Dividend [Yahoo! Finance]
2/13
06:33 pm
rprx
Royalty Pharma (NASDAQ:RPRX) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
Low
Report
Royalty Pharma (NASDAQ:RPRX) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
2/12
12:21 pm
rprx
Royalty Pharma: Strong Execution And Visible Pipeline Support Our Buy View [Seeking Alpha]
Low
Report
Royalty Pharma: Strong Execution And Visible Pipeline Support Our Buy View [Seeking Alpha]
2/12
10:07 am
rprx
Royalty Pharma (NASDAQ:RPRX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Royalty Pharma (NASDAQ:RPRX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
2/12
09:06 am
rprx
Royalty Pharma (NASDAQ:RPRX) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Low
Report
Royalty Pharma (NASDAQ:RPRX) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
2/11
04:48 pm
rprx
Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/11
04:48 pm
rprx
Royalty Pharma targets 3%–8% royalty receipts growth in 2026 while advancing $4.7B in transactions [Seeking Alpha]
Low
Report
Royalty Pharma targets 3%–8% royalty receipts growth in 2026 while advancing $4.7B in transactions [Seeking Alpha]
2/11
10:03 am
rprx
Royalty Pharma Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Royalty Pharma Q4 Earnings Call Highlights [Yahoo! Finance]